Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Irvine. Study-provided care at no cost to qualified participants.
Access multiple myeloma specialists in Irvine at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
This phase 3 randomized, open-label multicenter trial will compare the efficacy, safety and the impact on health-related quality of life (HR-QoL) of SPd versus EloPd in pomalidomide-naïve patients with MM who have received 1 to 4 prior anti-MM regimens and been treated with an immunomodulatory imide drug (IMiD), proteasome inhibitor (PI) and an anti-CD38 monoclonal antibody (mAb).
Sponsor: Stichting European Myeloma Network
Check if you qualify for this multiple myeloma clinical trial in Irvine, CA
If you're searching for multiple myeloma treatment options in Irvine, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Irvine research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.